Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity.

Li D. et al, (2022), Commun Biol, 5

Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responses.

Yang H. et al, (2021), Cell reports, 35

HLA-E–restricted, Gag-specific CD8 + T cells can suppress HIV-1 infection, offering vaccine opportunities

Yang H. et al, (2021), Science Immunology, 6

Detailed and atypical HLA‐E peptide binding motifs revealed by a novel peptide exchange binding assay

Walters LC. et al, (2020), European Journal of Immunology

Interrogating the recognition landscape of a conserved HIV-specific TCR reveals distinct bacterial peptide cross-reactivity

Mendoza JL. et al, (2020), eLife, 9

Author Correction: Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding

Walters LC. et al, (2018), Nature Communications, 9

Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding

Walters LC. et al, (2018), Nature Communications, 9

Immune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.

Ganesh A. et al, (2016), AIDS Res Hum Retroviruses, 32, 791 - 800

Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Hansen SG. et al, (2016), Science, 351, 714 - 720

Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphisms.

Stewart-Jones GB. et al, (2012), Proc Natl Acad Sci U S A, 109, E3483 - E3492

Functional differences exist between TNFα promoters encoding the common -237G SNP and the rarer HLA-B*5701-linked A variant.

Simpson PD. et al, (2012), PLoS One, 7

An early HIV mutation within an HLA-B*57-restricted T cell epitope abrogates binding to the killer inhibitory receptor 3DL1.

Brackenridge S. et al, (2011), J Virol, 85, 5415 - 5422

The Antiviral Efficacy of HIV-Specific CD8(+) T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate

Ranasinghe SRF. et al, (2011), PLOS PATHOGENS, 7

Characterization of an HLA-C-restricted CTL response in chronic HIV infection

Makadzange AT. et al, (2010), European Journal of Immunology, 40, 1036 - 1041

Some lessons from the systematic production and structural analysis of soluble αβ T-cell receptors

van Boxel GI. et al, (2009), Journal of Immunological Methods, 350, 14 - 21

Lack of KIR3DS1 Binding to MHC Class I Bw4 Tetramers in Complex with CD8+ T Cell Epitopes

Gillespie GMA. et al, (2007), AIDS Research and Human Retroviruses, 23, 451 - 455

Cutting edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B

Thananchai H. et al, (2007), Journal of Immunology, 178, 33 - 37

Strong TCR Conservation and Altered T Cell Cross-Reactivity Characterize a B*57-Restricted Immune Response in HIV-1 Infection

Gillespie GMA. et al, (2006), The Journal of Immunology, 177, 3893 - 3902

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

Goonetilleke N. et al, (2006), Journal of Virology, 80, 4717 - 4728

Identification of a novel HLA B*57 restricted cytotoxic T-lymphocyte epitope within HIV-1 rev.

Makadzange AT. et al, (2006), AIDS, 20, 462 - 464

Load More

Include forthcoming?